Evidence map›Paper›PMID 40223375›Full record

ReviewWiley interdisciplinary reviews. Nanomedicine and nanobiotechnology

Microscale Delivery Systems for Hydrophilic Active Ingredients in Functional Consumer Goods.

Zhirui Guan, Daniele Baiocco, Andre Barros, Zhibing Zhang

Abstract readReview
In one paragraph

Review in Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhirui GuanSchool of Chemical Engineering, University of Birmingham, Birmingham, UK.ORCID 0009-0009-9701-0478
Daniele BaioccoHealthcare Technology Institute, School of Chemical Engineering, University of Birmingham, Birmingham, UK.ORCID 0000-0002-0572-5065
Andre BarrosProcter & Gamble, Brussels Innovation Centre, Strombeek-Bever, Belgium.
Zhibing ZhangSchool of Chemical Engineering, University of Birmingham, Birmingham, UK.ORCID 0000-0003-2797-9098

Funding

EPSRC, UK EP/V027654/1Procter and Gamble
6 · The paper itself

Abstract

Hydrophilic active ingredients play a crucial role in formulated consumer products, encompassing antioxidants, flavoring substances, and pharmaceuticals. Yet, their susceptibility to environmental factors, such as light, pH, temperature, and humidity, poses challenges to their stability and sustained release. Microencapsulation offers a promising avenue to address these challenges, facilitating stabilization, targeted delivery, and enhanced efficacy of hydrophilic actives. However, despite significant advancements in the field, microencapsulation of hydrophilic actives remains at the forefront of innovation. This is primarily due to the intrinsic characteristics of hydrophilic actives, including small molecular weight and thus high permeability through many microcarriers (e.g., shells), which often necessitate complex and costly technologies to be developed. Moreover, in light of escalating regulatory frameworks, the pursuit of biodegradable and other compliant materials suitable for the entrapment of hydrophilic ingredients is gaining momentum. These advancements aim to provide alternatives to currently used non-degradable synthetic polymer materials. Research is currently pushing towards meeting these regulatory constraints via cutting-edge technologies to engineer novel microscale delivery systems for hydrophilic active ingredients, including microcapsules, microspheres, microneedles, and micropatches. Although still in its infancy, this approach holds true potential for revolutionizing the future of formulated consumer goods.

Indexed as

Drug Delivery SystemsHumansHydrophobic and Hydrophilic Interactionsdrug deliveryhydrophilic active ingredientsmicrocapsulesmicromanipulationmicroneedlesmicropatchesmicrospheresmicrosponges

Identifiers

PMID40223375
PMCPMC11994985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.